Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future ...Middle East

PR Newswire - News
LUND, Sweden, Nov. 2, 2022 /PRNewswire/ -- Significant events during the quarter Significant events after the quarter · To ensure the long-term financing of the business, in September the company raised about SEK 74.7 million before issue expenses through a rights issue. The rights issue...

Hence then, the article about enzymatica ab interim report q3 2022 a broader role for coldzyme adds potential for the future was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Parade - before 11 hour & 18 minute


Latest News